Study Finds a ‘Unique Medical Structure’ of an Acne Treatment
In 2018, a drug called Sarecycline was approved for use in the United States. It was the first new antibiotic then, authorized to treat acne in over four decades.
At the present, Yale and the University of Illinois-Chicago researchers have discovered how the distinctive medical structure of the drug makes it effectual.
The said group of researchers' study is described to be "the most detailed biological assessment" for sarecycline, which is among the numerous tetracycline antibiotics used for acne treatment.
Other tetracycline antibiotics, as indicated in the report also include "minocycline and doxycycline." Researchers had their research findings reported on August 3 in Proceedings of the National Academy of Sciences.
ALSO READ: New Research Finds Major Depressive Episodes More Common Than Formerly Believed
New Findings
Researchers found that different from other tetracycline drugs, sarecycline binds to what's also called as messenger RNA or mRNA.
These are molecules within a cell providing a code for the production of proteins, specifically in bacterial ribosomes which are found in living cells, connect amino acids together..
Sarecycline, as well as the other tetracyclines cure acne by hindering bacterial protein synthesis. They block the function of ribosomes in "Cutibacterium" acnes, the pathogenic bacterium found in acne.
According to dermatology associate professor at Yale, Dr. Christopher Bunick, they show in their study that "sarecycline's structure matters."
Bunick, who's also the co-corresponding author of the research, added that "this mode of action" has not yet been observed in the past in this "class of antibiotics," and proposes that sarecycline has distinctive properties among the class of tetracycline.
Potential of Sarecycline
Notably, the researchers discovered in their study, an explanation for the reason sarecycline has quite q low profile of drug-resistance, enhancing its efficacy.
Additionally, sarecycline prevents the occurrence of TetM, which they described as "a ribosome guardian protein" which shields bacteria from external interference.
Bunick and his co-authors also explained that the more extensive inference of the research is that, "structural understanding" of tetracycline compounds could be utilized to devise better and more effective antibiotics.
This, the associate professor added, could lead to therapies with better and longer-lasting efficiency, less side effects and lower resistance to drug.
Bunick also elaborated that future agents could be useful not just for this particular skin condition, but perhaps, in other disorders and infections of the skin, as well.
DON'T MISS THIS: High Glucose Levels May Limit One's Capability to Do Aerobic Exercise
Facts About Acne
Acne is a lingering, inflammatory skin condition resulting in pimples and spots, particularly on the face, neck, upper arms, shoulders, neck and back.
Acne appears in different types. Among them include blackheads, cyst, whiteheads, nodules and pimples.
Furthermore, acne is the most frequently-acquired skin condition in the United States which affects millions of Americans each year.
This skin condition usually takes place during an individual's puberty, "When his sebaceous glands trigger." However, though not dangerous, acne appears at any age, and it can also leave scars in the skin.
Essentially, glands are producing oil, and are activated by male hormones which the adrenal glands produce in both male and female individuals.
According to research, about 85 percent of people in the US have acne in their skin from age 12 to 24 years old.
Treatment for acne need not always be through sarecycline. Some address this skin condition through proper diet, application of tea tree oil and moisturizers, and drinking of tea.
IN CASE YOU MISSED THIS: Penis Microbiota Predicts If the Female Partner of a Man Is Likely to Develop Bacterial Vaginosis
Aug 06, 2020 06:00 AM EDT